Innovative therapeutic approaches beyond mAbs will require new methods for future facility construction.
Friedrich Haefele
Advertisement
Friedrich Haefele, PhD, is head of Biopharma Fill & Finish Germany for Boehringer Ingelheim.
Articles by Friedrich Haefele
Advertisement
Latest Updated Articles
Maturing Aseptic Technologies Create More Flexible FacilitiesPublished: August 1st 2014 | Updated:
Advertisement
Advertisement
